Glaxosmithkline Pharmaceutical Cash Flow Annual

BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Sector: Biotechnology & Drugs
3,126.00 -44.15 (-1.39%)Updated : 18 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -18.73-18.13-16.87-15.62
Net Changein Cash 474.6829.23-251.25-119.00
Cash Taxes Paid 81.71254.23264.71120.51
Net Income/ Starting Line 1,255.19959.80837.37767.47
Total Cash Dividends Paid -749.38-541.57-1,525.50-506.64
Changesin Working Capital 103.12-193.20-310.45-0.64
Cashfrom Operating Activities 1,289.90582.02484.23810.75
Cash Interest Paid 1.311.801.401.99
Cashfrom Financing Activities -769.42-561.50-1,543.32-524.24
Depreciation/ Depletion 66.7969.6865.7768.19
Other Investing Cash Flow Items Total -21.0839.93851.89-370.87
Capital Expenditures -24.72-31.22-44.04-34.64
period Type ----
Non- Cash Items -135.20-254.26-108.46-24.27
Financing Cash Flow Items -1.31-1.80-0.96-1.99
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -45.808.71807.85-405.51
*All figures in crores except per share values
Recommended For You
Trending Stocks
266.90+6.65(2.56%)
941.85+17.95(1.94%)
162.50+2.65(1.66%)
1,099.10-60.75 (-5.24%)
1,901.05-28.85 (-1.49%)